Basically, all stock investments whether on OTC or
Post# of 36537
(Total Views: 175)
Posted On: 10/18/2019 3:14:09 PM
Basically, all stock investments whether on OTC or anywhere else are risks, with no guarantees, so this is nothing new. As I have stated over and over, I am in this for the long haul. Information though is the key, and it is not just for me, but for everyone involved. You have your opinion, which is to be respected, just as the opinion of everyone else.
Yes, people should do their due diligence, when buying stock, when on calls and asking questions and getting answers. Companies should be forthcoming when concerns arise as well. I have stated in the past, I worked for several Fortune 500 companies and when concerns arose, they made sure people were aware of what was going on to get out ahead of questions / issues. Nature of the game. Just stating facts.
90 days is the 25th, but NASDAQ states 90 consecutive days and that is the question on what impact of missing it this close causes. Hopefully, none.
Joe and his team have done a tremendous job in getting acquisitions, and kicking off the MSO process in Arizona and other places. The information that has come out on these has been informative, which I applaud him for as well as the NGIO information.
I look forward to the 10-K and other documentation that is coming as well as I know that revenue is up for Generex based what has been shown for the first part of the year at least.
We'll see what the future holds. Overall, either way, Generex will come out ahead in the long run.
Yes, people should do their due diligence, when buying stock, when on calls and asking questions and getting answers. Companies should be forthcoming when concerns arise as well. I have stated in the past, I worked for several Fortune 500 companies and when concerns arose, they made sure people were aware of what was going on to get out ahead of questions / issues. Nature of the game. Just stating facts.
90 days is the 25th, but NASDAQ states 90 consecutive days and that is the question on what impact of missing it this close causes. Hopefully, none.
Joe and his team have done a tremendous job in getting acquisitions, and kicking off the MSO process in Arizona and other places. The information that has come out on these has been informative, which I applaud him for as well as the NGIO information.
I look forward to the 10-K and other documentation that is coming as well as I know that revenue is up for Generex based what has been shown for the first part of the year at least.
We'll see what the future holds. Overall, either way, Generex will come out ahead in the long run.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼